Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Posts Tagged ‘James Roumell’

Roumell Asset Management Nominates Candidates for Transcept Pharmaceuticals Inc (TSPT)’s Board

Roumell Asset Management, led by Jim Roumell, disclosed, in a new filing with the Securities and Exchange Commission, a letter sent to the board of......(read more)

SC Fundamental Value Calls on Transcept Pharmaceuticals to Remove Four Board Members

SC Fundamental Value, Transcept: Transcept Pharmaceuticals Inc (NASDAQ:TSPT) was given support in the equity portfolio of SC Fundamental Value, a filing......(read more)

Hedge Fund Filings: After-Market 13D Watch

Hedge fund filings: After the markets’ close today, we saw a rush of 13D filings come into the SEC. Here’s a brief recap of each. 1) Crestview......(read more)